ADSC-Derived CCL8 Regulates HIF-1α Signaling and Promotes Colorectal Cancer Progression in a 3D Coculture Platform [0.03%]
来源于ADSC的CCL8调节HIF-1α信号并促进 colorectal cancer 进展的三维共培养平台
Jeong-Eun Yun,Yeseon Son,Jieun Seo et al.
Jeong-Eun Yun et al.
This study aimed to recapitulate adipose-tumor interactions within the colorectal cancer (CRC) tumor microenvironment (TME) and to elucidate the role of adipose-derived stem cells (ADSCs) in regulating CRC progression through cytokine-media...
Prospective Trial on Tolerability and Efficacy of Adjuvant Nedaplatin Plus Docetaxel for Non-Small Cell Lung Cancer [0.03%]
前瞻性研究评价培美曲塞联合顺铂作为非小细胞肺癌二线治疗的耐受性和疗效
Koji Teramoto,Ryosuke Kaku,Tomoyuki Igarashi et al.
Koji Teramoto et al.
Nedaplatin is a second-generation platinum compound with reduced nephrotoxicity compared with cisplatin. Given its favorable tolerability in advanced non-small cell lung cancer (NSCLC), we prospectively evaluated the tolerability and effica...
Ketogenic Diet and β-Hydroxybutyrate Suppress Bladder Cancer Growth and Enhance Anti-PD-L1 Immunotherapy Efficacy [0.03%]
生酮饮食和β-羟基丁酸抑制膀胱癌生长并增强抗PD-L1免疫治疗的效果
Yuan Zeng,Gangli Gu,Lin Yang et al.
Yuan Zeng et al.
The limited clinical efficacy of immune checkpoint inhibitors (ICIs) remains a major challenge in the treatment of bladder cancer (BCa). Here, we report that a ketogenic diet (KD) and its principal circulating metabolite, β-hydroxybutyrate...
Transporter-Associated Therapeutic Efficacy of an SMVT-Targeted Boron Carrier in Boron Neutron Capture Therapy [0.03%]
基于SMVT靶向的硼载体在BNCT中发挥运输介质作用的疗效研究
Kenichiro Eza,Kohei Tsujino,Rina Shidoh-Kazuki et al.
Kenichiro Eza et al.
Boron neutron capture therapy (BNCT) requires selective delivery of boron compounds to tumor cells to achieve therapeutic efficacy. In this study, a BNCT strategy centered on the sodium-dependent multivitamin transporter (SMVT)-targeted bio...
Bile-Derived Exosomal miR-196a/-196b as Diagnostic Biomarkers Associated With Tumor Progression in Biliary Tract Cancer [0.03%]
胆汁来源的外泌体miR-196a/-196b作为胆道癌诊断及肿瘤进展相关的生物标志物
Naotaka Kugiyama,Katsuya Nagaoka,Takehisa Watanabe et al.
Naotaka Kugiyama et al.
Bile-based liquid biopsy presents a promising approach for identifying novel biomarkers for biliary tract cancer (BTC) given its proximity to tumor sites. The aim of this study was to identify bile-derived exosomal microRNAs (miRNAs) with d...
Final Analysis of Neoadjuvant Sintilimab Plus Chemotherapy in IB-IIIA Non-Small-Cell Lung Cancer: Phase 2 neoSCORE Trial [0.03%]
恩沃利单抗联合化疗新辅助治疗IB至IIIA期非小细胞肺癌的最终分析:Ⅱ期neoSCORE研究
Miner Shao,Jie Yao,Lufeng Zhao et al.
Miner Shao et al.
The optimal number of neoadjuvant chemoimmunotherapy cycles for resectable non-small cell lung cancer (NSCLC) remains uncertain. The randomized phase 2 neoSCORE trial (NCT04459611) conducted a comprehensive final analysis, comparing the out...
Elucidating the Pro-Tumor Role of LncRNA CROCCP2 in Glioma via the miR-5584-5p/HOXD11/Autophagy Pathway [0.03%]
通过miR-5584-5p/HOXD11/自噬途径阐明长链非编码RNA CROCCP2在胶质瘤中发挥的促肿瘤作用
Feng Wang,Ganni Lei,Yuan Peng et al.
Feng Wang et al.
Glioma is the most common primary malignant tumor of the central nervous system, characterized by high invasiveness and a high recurrence rate. The clinical therapeutic efficacy remains limited, necessitating the exploration of novel molecu...
Gastric Mucosal Molecular Alterations and Multimodal Field-Based Risk Models for Gastric Cancer Development [0.03%]
胃黏膜分子改变及多模态场模型在胃癌发生中的作用
Genki Usui,Atsushi Kaneda
Genki Usui
Gastric cancer risk involves Helicobacter pylori infection, lifestyle and environmental exposures, host susceptibility, and precancerous mucosal changes, such as atrophy and intestinal metaplasia. Although clinical, endoscopic, and histolog...
Ezh2 Inhibits the Differentiation of Short-Lived Effector CD8+ T Cells and Promotes T Cell-Dependent Antitumor Immunity [0.03%]
Ezh2通过抑制效应CD8+T细胞分化促进基于T细胞的抗肿瘤免疫
Kenji Takagi,Junpei Suzuki,Yuko Matsuoka et al.
Kenji Takagi et al.
Appropriate regulation of the differentiation balance between effector CD8+ T cells and memory CD8+ T cells is crucial for an appropriate immune response. We previously reported that the tumor suppressor menin suppresses the differentiation...
Combined MEK1/2 and Autophagy Inhibition Suppresses Tumor Growth via STING-Mediated Type I Interferon Response in iCCA [0.03%]
组合MEK1/2和自噬抑制通过STING介导的I型干扰素反应抑制iCCA肿瘤生长
Chengqiang Sun,Zheng Gao,Enfu Dong et al.
Chengqiang Sun et al.
The RAF-MEK-ERK pathway contributes to many human cancers, including intrahepatic cholangiocarcinoma (iCCA). Although MEK is an important therapeutic target, MEK inhibitors (MEKis) have limited efficacy as monotherapy in iCCA, and the under...